CN Patent

CN1525856A — 含吡唑啉酮衍生物的稳定的高浓度注射剂

Assigned to Tanabe Pharma Corp · Expires 2004-09-01 · 22y expired

What this patent protects

一种注射剂，含有3～60mg/mL的吡唑啉酮衍生物，典型为Edaravone、其生理可接受盐、或这些物质的水合物或溶剂化物作为有效成分。其具有长期稳定性，利于产品保存，并有很好的实用性。

USPTO Abstract

一种注射剂，含有3～60mg/mL的吡唑啉酮衍生物，典型为Edaravone、其生理可接受盐、或这些物质的水合物或溶剂化物作为有效成分。其具有长期稳定性，利于产品保存，并有很好的实用性。

Drugs covered by this patent

Patent Metadata

Patent number
CN1525856A
Jurisdiction
CN
Classification
—
Expires
2004-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.